Late-Onset Seizures: Trial of Vascular Risk Investigation and Treatment

Condition(s) studied

Investigational drug(s) / intervention(s)

Vascuar risk factor screening (blood pressure, medical history, BMI, laboratory tests): The vascular risk assessment is outlined below, there may be slight variations according to local routines. Overall, the screening should include: Family history of vascular disease Tests/examinations (order or obtain from medical records \[past 3 months\]) Weight Height Waist circumference 12-lead ECG Resting and standing blood pressure Total cholesterol HDL cholesterol LDL cholesterol HbA1c High sensitivity CRP Serum creatinine Urine albumin-to-creatinine ratio Medical history Atherosclerotic cardiovascular disease Atrial fibrillation Congestive heart failure Diabetes mellitus Hypertension Kidney disease Life-style risk factors (smoking, exercis

Study summary

A growing body of evidence suggests patients with late-onset seizures are at an increased risk of stroke, but the potential for reducing cardiovascular morbidity through risk factor screening and management is unknown.

The investigators aim to determine whether individuals with new-onset unprovoked seizures after middle age should undergo vascular risk assessment. In a cluster project the investigators assess the effect of vascular risk factor screening in an observational study as well as a cohort study.

The project has two interlinked components: a prospective single group study, in which risk factor assessment is performed and subsequent management is followed for one year; and a register-based cohort study examining the long-term effects of the intervention on a system level.

Eligibility

Primary outcome measure(s)

• Proportion with pharmacological intervention — 1 year
  The proportion with pharmacological intervention of modifiable vascular risk factors.

Trial sites (3)

More Sahlgrenska University Hospital trials in Sweden

Other trials for the same condition